Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed Dec 2, 2025
- Accession no.
- 0001636178-25-000008
- Filed
- Dec 2, 2025
- Trade date
- Dec 1, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.1M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | MOption exerciseAcquired | +21,000 | $146.03 | +$3,066,630 | 29,142 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −2,853 | $477.98F2 | −$1,363,676.94 | 26,289 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −4,198 | $479.11F3 | −$2,011,303.78 | 22,091 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −7,552 | $479.92F4 | −$3,624,355.84 | 14,539 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −3,858 | $480.95F5 | −$1,855,505.1 | 10,681 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,476 | $481.80F6 | −$711,136.8 | 9,205 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −903 | $483.04F7 | −$436,185.12 | 8,302 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −160 | $484.68 | −$77,548.8 | 8,142 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | MOption exerciseDisposed | −517 | $0.00 | $0 | 0 | Direct | |
| Dec 1, 2025 | Common Stock | MOption exerciseDisposed | −20,483 | $0.00 | $0 | 24,517 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $477.41 to $478.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $478.42 to $479.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $479.42 to $480.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $480.44 to $481.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $481.45 to $482.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $482.64 to $483.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.